UNSPSC 41131505: Red cell indices device

In this classification, a red cell indices device, usually part of a larger system, calculates or directly measures the erythrocyte mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC). US FDA regulates Red cell indices device under 21 CFR 864.5300 and under FDA product code KQH.

UNSPSC 41131505 Red cell indices device is a Commodity code tracking laboratory hematology analyzers and consumables used in blood testing and screening applications by state health departments and academic medical laboratories. State and local governments procure under this code hemoglobin testing systems (including compact analyzers, rack loaders, and associated power supplies), proficiency testing samples for quality assurance in hematology procedures, and specialized ICP-MS consumables for blood lead analysis screening in pediatric populations. The issuing bodies soliciting under the code are state health departments and university laboratory systems; Texas Health and Human Services Commission (HHSC) and its Department of State Health Services (DSHS) appear as repeat buyers in the recent record.

Texas dominates the recent procurement activity under this code. Representative recent opportunities include HHSC's IFB HHS0017310 (posted May 1, 2026, due May 18, 2026) for a D-10 Hemoglobin Testing System with Rack Loader for the South Texas Lab in Harlingen, with historical spending guidance of $45,050 to $80,000 for fiscal year 2025; HHSC's IFB HHS0017071 (posted February 18, 2026, due March 5, 2026) for PerkinElmer ICP-MS consumables and supplies used in pediatric blood lead screening, with historical spend data of $20,000 to $30,000; and the University of Wisconsin-Madison's competitive bid solicitation 2026-UWMSN-01287-RFB (posted April 3, 2026, due May 5, 2026) for custom-made Hematology/Whole Blood Chemistry Proficiency Testing Samples submitted through the ShopUW+ procurement portal. None of the solicitations identified incumbent vendors, set-aside designations, or guaranteed volumes; all contracts are contingent on fund availability and subject to executive or administrative approval.